Optimization of light sources for prostate photodynamic therapy

about

A review of in-vivo optical properties of human tissues and its impact on PDT Automatic interstitial photodynamic therapy planning via convex optimization.

P2860

Q26992342-3190CCEF-B886-4617-AA04-8B9A83133D30 Q51738687-B59CE16C-D136-44DE-A6D0-D863B7A8F35B

P2860

Optimization of light sources for prostate photodynamic therapy

Item

http://www.wikidata.org/entity/Q35795362

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Optimization of light sources for prostate photodynamic therapy

@ast

Optimization of light sources for prostate photodynamic therapy

@en

type

Item

label

Optimization of light sources for prostate photodynamic therapy

@ast

Optimization of light sources for prostate photodynamic therapy

@en

prefLabel

Optimization of light sources for prostate photodynamic therapy

@ast

Optimization of light sources for prostate photodynamic therapy

@en

P1476

Optimization of light sources for prostate photodynamic therapy

@en

P2093

Jun Li

http://www.w3.org/2001/XMLSchema#string

Martin D Altschuler

http://www.w3.org/2001/XMLSchema#string

Stephen M Hahn

http://www.w3.org/2001/XMLSchema#string

P2860

Global convergence analysis of fast multiobjective gradient-based dose optimization algorithms for high-dose-rate brachytherapy

Photodynamic therapy in the canine prostate using motexafin lutetium.

Light distributions from point, line and plane sources for photochemical reactions and fluorescence in turbid biological tissues.

Interstitial photodynamic therapy in the canine prostate.

Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.

Photodynamic therapy in the treatment of cancer: current state of the art.

Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy

Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy

Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.

Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer.

P304

186-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1117/12.590343

http://www.w3.org/2001/XMLSchema#string

P478

5689

http://www.w3.org/2001/XMLSchema#string

P50

Timothy C. Zhu

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26136612

http://www.w3.org/2001/XMLSchema#string

P932

4484893

http://www.w3.org/2001/XMLSchema#string

Optimization of light sources for prostate photodynamic therapy

about

P2860

P2860

Optimization of light sources for prostate photodynamic therapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932